Financhill
Back

AtriCure 10K Form

Sell
38

ATRC
AtriCure

Last Price:
34.02
Seasonality Move:
3.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATRC News And Ratings

See the #1 stock for the next 7 days that we like better than ATRC

ATRC Financial Statistics

Sales & Book Value

Annual Sales: $399.25M
Cash Flow: $1.24M
Price / Cash Flow: 0
Annual Sales: $9.81
Price / Book: 3.47

Profitability

EPS (TTM): -0.66000
Net Income (TTM): $-30.44M
Gross Margin: $300.37M
Return on Equity: -6.61%
Return on Assets: -5.11%

AtriCure Earnings Forecast

Key AtriCure Financial Ratios

  • The Gross Profit Margin over the past 23 years for ATRC is 75.23%.
  • The Selling, General & Administrative Expenses for ATRC have been equal to 63.40% of Gross Profit Margin.
  • The Research & Development expenses have been 18.51% of Revenue.
  • The Interest Expense is -22.75% of Operating Income.
  • The Net Earning history of ATRC is -7.62% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 10 years.

AtriCure Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Instruments & Supplies
Sector: Healthcare
Current Symbol: ATRC
CUSIP: 04963C
Website: atricure.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 3.57
Quick Ratio: 2.55

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATRC Technical Analysis vs Fundamental Analysis

Sell
38
AtriCure (ATRC) is a Sell

Is AtriCure a Buy or a Sell?

  • AtriCure stock is rated a Sell
    The current AtriCure [ATRC] share price is $34.00. The Score for ATRC is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.